Alejandro Galindo - May 18, 2022 Form 4/A - Amendment Insider Report for MANNKIND CORP (MNKD)

Role
EVP Endocrine Business Unit
Signature
/s/ Alejandro Galindo
Stock symbol
MNKD
Transactions as of
May 18, 2022
Transactions value $
$15,277
Form type
4/A - Amendment
Date filed
5/25/2022, 08:00 PM
Date Of Original Report
May 25, 2022
Previous filing
May 12, 2022
Next filing
Aug 24, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MNKD Common Stock, $.01 Par Value Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities $15.3K +4.79K +0.62% $3.19 777K May 18, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This report corrects total amount of securities beneficially owned as no shares were withheld to satisfy the tax liability incident on 5/18/2022 for the vesting of previously reported restricted stock units.